Back to Search
Start Over
Patterns of response and acquired resistance to the programmed death-1 inhibitor pembrolizumab in Stage III metastatic cutaneous squamous cell carcinoma.
- Source :
-
Dermatologic therapy [Dermatol Ther] 2019 Nov; Vol. 32 (6), pp. e13107. Date of Electronic Publication: 2019 Oct 21. - Publication Year :
- 2019
- Subjects :
- Aged
Carcinoma, Squamous Cell pathology
Drug Resistance, Neoplasm
Humans
Male
Neoplasm Staging
Skin Neoplasms pathology
Antibodies, Monoclonal, Humanized therapeutic use
Carcinoma, Squamous Cell drug therapy
Programmed Cell Death 1 Receptor antagonists & inhibitors
Skin Neoplasms drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1529-8019
- Volume :
- 32
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Dermatologic therapy
- Publication Type :
- Report
- Accession number :
- 31595596
- Full Text :
- https://doi.org/10.1111/dth.13107